Printer Friendly

PHARMACEUTICAL RESOURCES APPOINTS NEW CHIEF FINANCIAL OFFICER

 SPRING VALLEY, N.Y., May 20 /PRNewswire/ -- Pharmaceutical Resources, Inc. (NYSE: PRX; PSE) today reported the appointment of Robert I. Edinger as the company's new vice president and chief financial officer.
 From 1983 to 1989, Mr. Edinger served as chief financial officer and president of Ketchum & Co. Inc., the ninth largest wholesale drug company in the United States. Mr. Edinger comes to Pharmaceutical Resources from Bonjour Group Ltd., a privately held international licensing company, where he served as executive vice president. He has over 25 years experience as a certified public accountant, chief financial officer, chief operating officer and as chief executive officer of various private and public companies.
 "The appointment of Bob Edinger is a major step in the final phase of the reorganization of the management team and I am counting on him to develop the financial strategies and operating systems to accelerate the continued growth and profitability of our company," said Kenneth I. Sawyer, president of Pharmaceutical Resources.
 Pharmaceutical Resources, Inc., through its subsidiaries, manufacturers and markets prescription and over-the-counter generic pharmaceuticals.
 -0- 5/20/93
 /CONTACT: Kenneth I. Sawyer, president of Pharmaceutical Resources, 914-425-7100/
 (PRX)


CO: Pharmaceutical Resources, Inc. ST: New York IN: MTC SU: PER

CK-KD -- NY072 -- 0799 05/20/93 13:11 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:May 20, 1993
Words:209
Previous Article:MFS COMMUNICATIONS COMPANY, INC. ANNOUNCES INITIAL PUBLIC OFFERING; TRADING BEGINS TODAY ON NASDAQ NATIONAL MARKET SYSTEM UNDER SYMBOL MFST
Next Article:CELGENE CORPORATION DESIGNS AND DELIVERS NEW MOBILE REACTOR DEMONSTRATION UNIT; COMPANY ALSO EXPANDS BIOTREATMENT CAPABILITIES
Topics:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters